Anxiety

What’s not to like about a world in which youths are involved in fewer car accidents, drink less and wrestle with fewer unplanned pregnancies? Well, think about it. Those kids might not be wiser; they might simply be afraid of everything. And what has got them so afraid? A little glass rectangle, ‘a portal in their pockets’, that entices them into a world that’s ‘exciting, addictive, unstable and… unsuitable for children’. So far, so paranoid – and there’s a delicious tang of the documentary maker Adam Curtis about the social psychologist Jonathan Haidt’s extraordinarily outspoken and well-evidenced diatribe against the creators of smartphone culture. These men, says Haidt,  were once

We are in the midst of a ‘psychedelic renaissance’. Not since the 1950s and early 1960s has there been so much interest in researching the therapeutic potential of psychedelics. The FDA approved a ketamine derivative for medicinal use in 2019, and has given both MDMA and psilocybin (the psycho-active ingredient in magic mushrooms) ‘breakthrough therapy’ status, putting the drugs on a fast track to approval in the US, with the UK likely to follow suit. Professor David Nutt is a neuropsycho-pharmacologist (say that three times fast) and head of the Centre for Psychedelic Research at Imperial College, London. He was the UK’s ‘drug tsar’ before getting sacked in 2009 for